Home >> Materials & Chemicals >> Consumer Goods >>

Global Active Pharmaceutical Ingredients (API) Market Report 2018 - Industry Analysis, Size, Share, Trends, Segment and Forecasts to 2025

Published: Jan-2019 | Format: PDF | MAResearch | Number of pages: 128 | Code: MRS - 395252

The global Active Pharmaceutical Ingredients (API) market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028.

This report provides detailed historical analysis of global market for Active Pharmaceutical Ingredients (API) from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Active Pharmaceutical Ingredients (API) market.

Leading players of Active Pharmaceutical Ingredients (API) including:
    Teva
    Mylan
    DSM
    Aurobindo Pharma
    Aspen
    Novartis
    BASF
    Pfizer
    Huahai Pharmaceutical
    Hisun Pharmaceutical
    Sun Pharmaceutical Industries
    Zhejiang Medicine
    Dr. Reddy’s Laboratories
    Zhejiang NHU
    Bayer
    NCPC
    AbbVie
    Shandong Xinhua Pharmaceutical
    Northeast Pharm
    Harbin Pharmaceutical
    LKPC

Market split by Type, can be divided into:
    Synthetic APIs
    Biotech APIs

Market split by Application, can be divided into:
    CNS
    Cardiovascular
    Genitourinary/Hormonal Drugs
    Respiratory
    Rheumatology
    Diabetes

Market split by Sales Channel, can be divided into:
    Direct Channel
    Distribution Channel

Market segment by Region/Country including:
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Spain etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
    South America Brazil, Argentina, Colombia and Chile etc.)
    Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Active Pharmaceutical Ingredients (API) Market Overview
    1.1 Active Pharmaceutical Ingredients (API) Definition
    1.2 Global Active Pharmaceutical Ingredients (API) Market Size Status and Outlook (2013-2028)
    1.3 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Region (2013-2028)
    1.4 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Type (2013-2028)
    1.5 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Application (2013-2028)
    1.6 Global Active Pharmaceutical Ingredients (API) Market Size Comparison by Sales Channel (2013-2028)
    1.7 Active Pharmaceutical Ingredients (API) Market Dynamics
        1.7.1 Market Drivers/Opportunities
        1.7.2 Market Challenges/Risks
        1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Player
    2.1 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Player (2016-2018)
    2.2 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Player (2016-2018)
    2.3 Global Active Pharmaceutical Ingredients (API) Average Price by Player (2016-2018)
    2.4 Players Competition Situation & Trends
    2.5 Conclusion of Segment by Player
Chapter 3 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Type
    3.1 Global Active Pharmaceutical Ingredients (API) Market by Type
        3.1.1 Synthetic APIs
        3.1.2 Biotech APIs
    3.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Type (2013-2018)
    3.3 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Type (2013-2018)
    3.4 Global Active Pharmaceutical Ingredients (API) Average Price by Type (2013-2018)
    3.5 Leading Players of Active Pharmaceutical Ingredients (API) by Type in 2017
    3.6 Conclusion of Segment by Type
Chapter 4 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Application
    4.1 Global Active Pharmaceutical Ingredients (API) Market by Application
        4.1.1 CNS
        4.1.2 Cardiovascular
        4.1.3 Genitourinary/Hormonal Drugs
        4.1.4 Respiratory
        4.1.5 Rheumatology
    4.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Application (2013-2018)
    4.3 Leading Consumers of Active Pharmaceutical Ingredients (API) by Application in 2017
    4.4 Conclusion of Segment by Application
Chapter 5 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Sales Channel
    5.1 Global Active Pharmaceutical Ingredients (API) Market by Sales Channel
        5.1.1 Direct Channel
        5.1.2 Distribution Channel
    5.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Sales Channel (2013-2018)
    5.3 Leading Distributors/Dealers of Active Pharmaceutical Ingredients (API) by Sales Channel in 2017
    5.4 Conclusion of Segment by Sales Channel
Chapter 6 Active Pharmaceutical Ingredients (API) Market Segment Analysis by Region
    6.1 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR by Region (2013-2028)
    6.2 Global Active Pharmaceutical Ingredients (API) Sales and Market Share by Region (2013-2018)
    6.3 Global Active Pharmaceutical Ingredients (API) Revenue and Market Share by Region (2013-2018)
    6.4 North America
        6.4.1 North America Market by Country
        6.4.2 North America Active Pharmaceutical Ingredients (API) Market Share by Type
        6.4.3 North America Active Pharmaceutical Ingredients (API) Market Share by Application
        6.4.4 United States
        6.4.5 Canada
        6.4.6 Mexico
    6.5 Europe
        6.5.1 Europe Market by Country
        6.5.2 Europe Active Pharmaceutical Ingredients (API) Market Share by Type
        6.5.3 Europe Active Pharmaceutical Ingredients (API) Market Share by Application
        6.5.4 Germany
        6.5.5 UK
        6.5.6 France
        6.5.7 Italy
        6.5.8 Russia
        6.5.9 Spain
    6.6 Asia-Pacific
        6.6.1 Asia-Pacific Market by Country
        6.6.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Share by Type
        6.6.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Share by Application
        6.6.4 China
        6.6.5 Japan
        6.6.6 Korea
        6.6.7 India
        6.6.8 Southeast Asia
        6.6.9 Australia
    6.7 South America
        6.7.1 South America Market by Country
        6.7.2 South America Active Pharmaceutical Ingredients (API) Market Share by Type in 2017
        6.7.3 South America Active Pharmaceutical Ingredients (API) Market Share by Application in 2017
        6.7.4 Brazil
        6.7.5 Argentina
        6.7.6 Colombia
        6.7.7 Chile
    6.8 Middle East & Africa
        6.8.1 Middle East & Africa Market by Country
        6.8.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Share by Type
        6.8.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Share by Application
        6.8.4 Egypt
        6.8.5 Saudi Arabia
        6.8.6 South Africa
        6.8.7 Nigeria
    6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Active Pharmaceutical Ingredients (API) Players
    7.1 Teva
        7.1.1 Company Snapshot
        7.1.2 Product/Business Offered
        7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
        7.1.4 Strategy and SWOT Analysis
    7.2 Mylan
    7.3 DSM
    7.4 Aurobindo Pharma
    7.5 Aspen
    7.6 Novartis
    7.7 BASF
    7.8 Pfizer
    7.9 Huahai Pharmaceutical
    7.10 Hisun Pharmaceutical
    7.11 Sun Pharmaceutical Industries
    7.12 Zhejiang Medicine
    7.13 Dr. Reddy’s Laboratories
    7.14 Zhejiang NHU
    7.15 Bayer
    7.16 NCPC
    7.17 AbbVie
    7.18 Shandong Xinhua Pharmaceutical
    7.19 Northeast Pharm
    7.20 Harbin Pharmaceutical
    7.21 LKPC
Chapter 8 Upstream and Downstream Analysis of Active Pharmaceutical Ingredients (API)
    8.1 Industrial Chain of Active Pharmaceutical Ingredients (API)
    8.2 Upstream of Active Pharmaceutical Ingredients (API)
        8.2.1 Raw Materials
        8.2.2 Labor Cost
        8.2.3 Manufacturing Expenses
        8.2.4 Manufacturing Cost Structure
        8.2.5 Manufacturing Process
    8.3 Downstream of Active Pharmaceutical Ingredients (API)
        8.3.1 Leading Distributors/Dealers of Active Pharmaceutical Ingredients (API)
        8.3.2 Leading Consumers of Active Pharmaceutical Ingredients (API)
Chapter 9 Development Trend of Active Pharmaceutical Ingredients (API) (2018-2028)
    9.1 Global Active Pharmaceutical Ingredients (API) Market Size (Sales and Revenue) Forecast (2018-2028)
    9.2 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Region (2018-2028)
    9.3 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Type (2018-2028)
    9.4 Global Active Pharmaceutical Ingredients (API) Market Size and CAGR Forecast by Application (2018-2028)
    9.5 Global Active Pharmaceutical Ingredients (API) Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
    10.1 Research Methodology
    10.2 Data Sources
    10.3 Disclaimer
    10.4 Analysts Certification


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)2500 View Pricing